In a full-year earnings update last month, the company said infant nutrition sales had grown at a low single-digit rate, driven by sales of its pricier formula NAN and its mass-market brand Lactogen.
China Feihe Ltd, a leading infant formula brand in China, announced on March 26 that it will roll out a subsidy program aimed ...